CARSON CITY, Nev., Dec. 30 /PRNewswire-FirstCall/ -- Niusule Biotech Corp., a Nevada corporation formed on April 8, 2008, announced today that its shares of common stock will begin trading on the OTC Bulletin Board under the symbol "NIUS" on December 30th, 2008.
For a NIUS quote, visit: http://finance.yahoo.com/q?s=NIUS.OB
"Our main business will be operated in China through our subsidiary Zhejiang Baitai Bioengineering Corp by manufacturing and selling biopharmaceutical and health food," said Qinghua Hu, Chairman of Niusule Biotech Corp. "We believe our public listing is a signal of Niusule Biotech Corp.'s maturity as a company. I would like to thank Niusule Biotech Corp.'s partners, employees and shareholders for their respective roles in contributing to our success."
In a meeting with employees, directors, and shareholders, Hu discussed Niusule Biotech Corp. goals and priorities as a publicly traded entity including:
-- Build long-term value for shareholders by implementing our business plan; -- Seek cooperation and alliance with US companies manufacturing health food products for either distribution or production rights in China; and -- Commitment to being a leading player in China's health food industry and bioengineering industry.
"As we are in our initial stages of growth, we provide both small and institutional investors opportunities to invest in China's health food industry," said Hu. "The move to the OTC Bulletin Board positions the company to benefit from greater visibility and liquidity."
About Niusule Biotech Corp.
Founded in 2008, Niusule Biotech Corp.'s main business will be operated in
China through our subsidiary Zhejiang Baitai Bioengineering Corp. Niusule
Biotech Corp. is trying to build a bridge between th
|SOURCE Niusule Biotech Corp.|
Copyright©2008 PR Newswire.
All rights reserved